Related Experiment Video

Updated: Jun 6, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies

C Schmidt1, M Bloomston, M H Shah

  • 1Department of Surgery, The Ohio State University, Columbus, OH, USA.

Oncogene
|December 7, 2010
PubMed

Insights

Neuroendocrine tumors (NETs) are challenging malignancies. Current treatments focus on loco-regional and targeted therapies, as chemotherapy shows limited efficacy, highlighting the need for clinical trials.

Area of Science:

  • Oncology
  • Endocrinology
  • Medical Research

Background:

  • Neuroendocrine tumors (NETs) represent a heterogeneous group of cancers with unpredictable outcomes.
  • Traditional chemotherapy offers limited efficacy for pancreatic NETs and carcinoid tumors.
  • Current management strategies for metastatic NETs involve loco-regional interventions and targeted biological agents.

Purpose of the Study:

  • To review the current treatment landscape for neuroendocrine tumors (NETs).
  • To emphasize the limited role of conventional chemotherapy in NET management.
  • To highlight the importance of clinical trials for advancing NET therapeutics.

Main Methods:

  • Literature review of current therapeutic approaches for NETs.
  • Analysis of treatment efficacy for pancreatic NETs and carcinoid tumors.
  • Discussion of the role of loco-regional and targeted therapies.

Main Results:

  • Cytotoxic chemotherapies exhibit minimal activity against NETs.
  • Loco-regional therapies and targeted biological agents are primary treatment modalities for metastatic disease.
  • Clinical trials are essential for evaluating novel therapeutic options.

Conclusions:

  • Neuroendocrine tumors require specialized treatment approaches beyond traditional chemotherapy.
  • Targeted therapies and loco-regional treatments are crucial for managing metastatic NETs.
  • Ongoing clinical trials are vital for discovering and validating new treatments for NET patients.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...